Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
With
Dra. Pilar Escribano Subías - Coordinator - HU 12 de Octubre - Madrid (Spain)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients \> 18 years of age.
Patients in New York Heart Association (NYHA) functional class II-IV pulmonary hypertension who are treated with Ventavis at least three months before and who use -neb ® AAD ® system.
Patients who accepted participation in the study and sign informed consent.
Patients with ability to understand and follow the instructions and are able to participate for the duration of the study.
You may not be if
Patients with severe cognitive impairment.
Geographically unstable patients who can not be followed during the 12 month study.
Patients who have a life expectancy of at least 12 months.
Patients who are participating in another study at the time of inclusion. .
Clareo Health | Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System
